All times are listed in CEST (Central European Summer Time)
Browsing Over 461 Presentations
Sort By
José Baselga: Cancer’s fiercest opponent (ID 49)
Welcome address from ESMO (ID 474)
Lecture Time
10:00 - 10:04
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Introduction of the documentary (ID 475)
Lecture Time
10:04 - 10:08
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Documentary (ID 476)
Lecture Time
10:08 - 11:05
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)
Panel discussion (ID 477)
Lecture Time
11:05 - 11:20
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Introduction (ID 267)
Lecture Time
11:30 - 11:30
Speakers
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Tumor Board 1: Current Management Options for HR+/HER2- Metastatic Breast Cancer (ID 268)
Lecture Time
11:30 - 11:30
Speakers
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)
Jumping the Gun - Should we wait for OS data in eBC? (ID 469)
Lecture Time
11:30 - 11:45
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration? (ID 3)
Clinical case presentation from the molecular tumor board (ID 18)
Lecture Time
11:30 - 11:30
Speakers
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Tumor Board 1: Investigating Novel Therapeutic Approaches (ID 269)
Lecture Time
11:30 - 11:40
Speakers
Authors
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)
What do we know About HER2-Low Breast Cancer? (ID 470)
Lecture Time
11:45 - 12:00
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration? (ID 3)
Panel discussion on the implementation of genomic profiling in clinical practice by multidisciplinary collaboration (ID 19)
Lecture Time
11:30 - 11:30
Authors
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Tumor Board 2: Evolving Management Paradigms for High-Risk Early-Stage HR+/HER2- Breast Cancer (ID 270)
Lecture Time
11:40 - 12:00
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30